KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Astrana Health (ASTH) Return on Sales (2016 - 2025)

Astrana Health (ASTH) has disclosed Return on Sales for 16 consecutive years, with 0.01% as the latest value for Q4 2025.

  • Quarterly Return on Sales rose 2.0% to 0.01% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.01% through Dec 2025, down 2.0% year-over-year, with the annual reading at 0.01% for FY2025, 2.0% down from the prior year.
  • Return on Sales hit 0.01% in Q4 2025 for Astrana Health, up from 0.0% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.32% in Q2 2021 to a low of 0.09% in Q4 2021.
  • Historically, Return on Sales has averaged 0.04% across 5 years, with a median of 0.04% in 2023.
  • Biggest YoY gain for Return on Sales was 10bps in 2022; the steepest drop was -28bps in 2022.
  • Year by year, Return on Sales stood at 0.09% in 2021, then soared by 97bps to 0.0% in 2022, then plummeted by -1083bps to 0.04% in 2023, then soared by 67bps to 0.01% in 2024, then skyrocketed by 159bps to 0.01% in 2025.
  • Business Quant data shows Return on Sales for ASTH at 0.01% in Q4 2025, 0.0% in Q3 2025, and 0.02% in Q2 2025.